Melatonin and its brain metabolite N(1)-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice.
about
Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemiaMelatonin: A Mitochondrial Targeting Molecule Involving Mitochondrial Protection and DynamicsMelatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor SymptomsAnti-Oxidants in Parkinson's Disease Therapy: A Critical Point of ViewCannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's DiseaseMelatonin metabolism in the central nervous system.Pomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson's disease.Development of urea and thiourea kynurenamine derivatives: synthesis, molecular modeling, and biological evaluation as nitric oxide synthase inhibitors.Melatonin Scavenger Properties against Oxidative and Nitrosative Stress: Impact on Gamete Handling and In Vitro Embryo Production in Humans and Other Mammals.Melatonin, noncoding RNAs, messenger RNA stability and epigenetics--evidence, hints, gaps and perspectives.Melatonin in mitochondrial dysfunction and related disordersTherapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.Toxin models of mitochondrial dysfunction in Parkinson's disease.Accumulation of exogenous amyloid-beta peptide in hippocampal mitochondria causes their dysfunction: a protective role for melatonin.Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.Melatonin enhances neural stem cell differentiation and engraftment by increasing mitochondrial function.Partial neural protection with prophylactic low-dose melatonin after asphyxia in preterm fetal sheep.The role of mitochondria in brain aging and the effects of melatonin.Mitochondrial DNA and inflammatory diseases.Melatonin as a natural ally against oxidative stress: a physicochemical examination.Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: is it all set to irrefutable clinical translation?A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives.On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK.Maternal melatonin administration mitigates coronary stiffness and endothelial dysfunction, and improves heart resilience to insult in growth restricted lambs.The role and therapeutic potential of melatonin in age-related ocular diseases.The mechanism of action of MPTP-induced neuroinflammation and its modulation by melatonin in rat astrocytoma cells, C6.Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthasesEffect of chronic L-dopa or melatonin treatments after dopamine deafferentation in rats: dyskinesia, motor performance, and cytological analysis.Melatonin inhibits manganese-induced motor dysfunction and neuronal loss in mice: involvement of oxidative stress and dopaminergic neurodegeneration.Taxon- and Site-Specific Melatonin Catabolism.Melatonin and the electron transport chain.Melatonin rescues zebrafish embryos from the parkinsonian phenotype restoring the parkin/PINK1/DJ-1/MUL1 network.Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production.Melatonin transport into mitochondria.Melatonin suppresses nitric oxide production in glial cultures by pro-inflammatory cytokines through p38 MAPK inhibition.
P2860
Q26999039-B0CB67E6-80D1-4C98-8174-91F1C5FA2D78Q28069321-FB22AEDA-7E51-4A60-8949-A5393D898DB9Q28075345-7B634F7C-F086-409E-AD22-CAC06907A987Q28084254-4606FD70-7FFD-49E0-B874-D85CB5B014F6Q28277871-6A28ABA1-0A65-4AC0-9396-5F97325322DFQ30476606-34FBF945-13FE-4801-88D5-61C58EDD705EQ30573637-48BC8C77-5C7F-4B96-A330-2F4350861AB7Q30914542-2AE91C11-B4C8-4BBB-9D15-59FAF7187986Q33838392-939C0B29-3D5C-4023-AB58-75AAA954ECB6Q34486777-0E547F80-667C-4E2B-913C-6FCE2998B4E4Q35001051-5CD2BF2B-43EB-429D-96BC-9B25075B4714Q35276597-FB409388-89E3-473D-97EA-7030C581D3DBQ35799141-96506387-26E0-4CD5-8B70-EF02650DC358Q35986729-B3EB9D35-7C88-42D1-9DA7-E287EC5FF2ACQ36040915-088AA600-CB22-40EA-B2AB-16B5052C63CFQ36351040-4963469F-FE5B-45B4-B7C2-1FDAD0CC5185Q37459886-8AA05662-0465-43B1-9F6E-D88104FB941DQ37848076-A682C9E9-A621-478D-8083-0C36EE18D773Q37898562-9C15460C-91B1-491E-9088-B26832DB1FF4Q37900675-230DCDB1-5B94-4642-A6E3-6DA21440A816Q37971339-AE133454-C4DA-4BEE-919D-86F8B5D0554DQ38020932-0C93421D-10A9-4E0E-B92F-3AD619123E7FQ38045452-16E2454A-2F6A-405E-9E0B-21F264101965Q39263899-33079E40-CAB5-4A22-B98E-083ACA8707F8Q39402838-034931A7-EF36-4328-8386-3E0598DCB504Q39659865-BBF2172D-9AFF-4109-8E6B-CE51EE6E9780Q41363567-53E81F30-59DC-4A23-B61A-F180900D358EQ42127267-5BF3F010-B7F3-4238-AFF7-63AE79F9A7A2Q42705031-07623A86-BADA-4157-A725-0E0E58AE40FBQ46257143-140E3B35-DDED-4C4E-8B16-8A18B868613CQ46324395-CBCE231B-080D-4ADE-964F-5F0DCA490EAAQ46967068-C318FD33-21B9-4B11-A300-2D0634C4FE73Q50630062-6BE954C6-FF6D-4EFD-AE5F-CE81B1C686F1Q53101536-FA327E1D-7BC2-4291-9968-659551C22FFBQ54407442-C76A7D09-9171-4A15-8821-29E9F95B847B
P2860
Melatonin and its brain metabolite N(1)-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Melatonin and its brain metabolite N
@nl
Melatonin and its brain metabo ...... nduction in parkinsonian mice.
@en
type
label
Melatonin and its brain metabolite N
@nl
Melatonin and its brain metabo ...... nduction in parkinsonian mice.
@en
prefLabel
Melatonin and its brain metabolite N
@nl
Melatonin and its brain metabo ...... nduction in parkinsonian mice.
@en
P2093
P50
P356
P1476
Melatonin and its brain metabo ...... induction in parkinsonian mice
@en
P2093
Antonio Entrena
Antonio Espinosa
Encarnación Camacho
Luis C López
María D Carrión
Miguel A Gallo
P304
P356
10.1002/JNR.22123
P577
2009-10-01T00:00:00Z